Go to Page # Page of 45

Arrhythmias and Clinical EP Atrial Fibrillation: Contemporary Management Strategies

 Samuel Asirvatham MD, Enrique Melgarejo Rojas MD
  12th-Sep-2017
Description: I receive royalties for work licensed through Mayo Clinic to a privately held company for contributions related to the use of nerve signal modulation to treat central, autonomic and peripheral nervous system disorders, including pain. Mayo Clinic receives royalties and owns equity in this company. The company does not currently license or manufacture any drug or device in the medical field.
Views: 847
Domain: Medical
Category: Therapy
LithoVision 2018
Contents:
Arrhythmias and Clinical EP
Atrial Fibrillation:
Contemporary Management Strategies
Samuel Asirvatham, MD & Enrique Melgarejo Rojas, MD

Saturday, June 24, 2017
2:40 to 3:25 p.m.

AF Ablation and
The Impact on Clinical Practice

Samuel J. Asirvatham, M.D.
Mayo Clinic – Rochester

©2012 MFMER | 3200268v1(2003)-3

Disclosures
Relevant financial relationship(s) with industry
•I rec ... See more

Recent Presentations

Clinical Use Of Stem Cells In Orthopaedics

Stem cell research arose from the need to explore new therapeutic possibilities for intractable and lethal diseases. Although musculoskeletal disorders are basically nonlethal, the

...
17 February, 2018
Arnold Evia
16 February, 2018
...
15 February, 2018